Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

26 mai 2016 08h00 HE | Source: Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals to Present at Two Upcoming June Events

BOTHELL, Wash., May 26, 2016 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today...
25 mai 2016 08h00 HE | Source: Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals Continues to Strengthen and Expand Leadership Team to Support Advancement of ALD403 for Migraine Prevention

Iqbal Husain, Ph.D., Appointed Vice President of Program and Portfolio Management Dauphine S. Barone Promoted to Vice President of Manufacturing Logistics Barbara A. Schaeffler, MBA, Promoted to...
06 mai 2016 08h15 HE | Source: Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals to Present at Bank of America Merrill Lynch 2016 Health Care Conference

BOTHELL, Wash., May 06, 2016 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced...
06 mai 2016 08h00 HE | Source: Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals Licenses Clazakizumab Rights to Vitaeris

BOTHELL, Wash., and VANCOUVER, British Columbia, May 06, 2016 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal...
28 avr. 2016 16h05 HE | Source: Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals Reports First Quarter 2016 Financial and Operating Results

BOTHELL, Wash., April 28, 2016 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today...
21 avr. 2016 08h00 HE | Source: Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals to Host Conference Call to Discuss First Quarter 2016 Financial and Operating Results

BOTHELL, Wash., April 21, 2016 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today...
12 avr. 2016 16h05 HE | Source: Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise in Full of Option to Purchase Additional Shares

BOTHELL, Wash., April 12, 2016 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company, announced today the closing of its previously announced...
08 avr. 2016 17h05 HE | Source: Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals to Present at 15th Annual Needham Healthcare Conference

BOTHELL, Wash., April 08, 2016 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the...
06 avr. 2016 22h39 HE | Source: Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals Prices Public Offering of Common Stock

BOTHELL, Wash., April 06, 2016 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company, announced today the pricing of an underwritten public...
06 avr. 2016 16h02 HE | Source: Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals Announces Commencement of Public Offering of Common Stock

BOTHELL, Wash., April 06, 2016 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR) , a clinical-stage biopharmaceutical company, announced today that it intends to offer and sell,...

Page précédente